Janus Life Sciences took part in the Eurasian Pharmaceutical Forum
Janus Life Sciences, a division of Janus Worldwide, participated in the 12th Annual Eurasian Pharmaceutical Forum, which took place on March 2–4 in Moscow at the Renaissance Moscow Monarch Centre, and also served as a language partner at the event.
The forum was held in offline format, and participants also had the opportunity to attend virtually. This year’s hybrid event format allowed significant expansion of the expert community present and an increase in the participant audience, which totaled over 350 people. Using a dedicated platform, online attendees were able to fully integrate into the event, ask questions and arrange meetings. Janus Life Sciences had its own stand.
The forum’s key topics this year included development features of the common pharmaceutical EAEU market, the COVID-19 pandemic and its impact on the market and pharmaceutical industry, registration of drugs according to common EAEU rules, and more. There was also an extended focus session on Uzbekistan, as well as focus sessions on selected EAEU and CIS countries.
The Eurasian Pharmaceutical Forum was an excellent platform for Janus Life Sciences to present itself as an expert in comprehensive linguistic support for medical and pharmaceutical companies: from traditional interpreting and translation to localization of websites, videos and other materials, layout, design and publishing. Discussion with potential and existing clients was productive and positive. Janus Life Sciences would like to note the high level of organization of the event as well as the informative and relevant content of the presentations. The team is happy to be part of this extensive and significant pharmaceutical world event.